WCM Investment Management
RYTM icon

WCM Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

WCM Investment Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86M Sell
80,552
-68
-0.1% -$6.15K 0.02% 161
2026
Q1 		$6.23M Buy
80,620
+35,815
+80% +$3.48M 0.01% 175
2025
Q4 		$4.78M Sell
44,805
-2,928
-6% -$311K 0.01% 180
2025
Q3 		$4.8M Buy
+47,733
New +$4.43M 0.01% 166

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WCM Investment Management's RYTM Position: Q2 2026 in Review

WCM Investment Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 0.08% in Q2 2026, selling an estimated $6.15K and leaving 80,552 shares worth $8.86M. The position accounts for 0.02% of the portfolio, ranked #161.

WCM Investment Management first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • WCM Investment Management held 80,552 shares of Rhythm Pharmaceuticals worth $8.86M as of Q2 2026.
  • WCM Investment Management sold 68 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $6.15K.
  • Rhythm Pharmaceuticals made up 0.02% of WCM Investment Management's portfolio in Q2 2026, its #161 holding.
  • WCM Investment Management first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.